Enzyme Structure and Catalysis (5E)
Help Questions
MCAT Chemical and Physical Foundations of Biological Systems › Enzyme Structure and Catalysis (5E)
A competitive inhibitor I has $K_i=5\ \mu$M for an enzyme with $K_m=10\ \mu$M. In an assay with I = 5 \muM, $V_{max}$ is unchanged. Which statement is most consistent with the observed kinetics?
Both $V_{max}$ and $K_m$ decrease because inhibitor binds only to ES.
Apparent $K_m$ increases because inhibitor binding reduces free enzyme available to bind substrate at low [S].
Apparent $K_m$ decreases because inhibitor binding stabilizes ES and promotes catalysis.
Apparent $K_m$ is unchanged because competitive inhibitors only affect $V_{max}$.
Explanation
This question tests understanding of competitive inhibition kinetics and the relationship between Ki and inhibitor effectiveness. For competitive inhibition, the apparent Km increases by a factor of (1 + [I]/Ki), so with [I] = Ki = 5 μM, the apparent Km doubles from 10 to 20 μM while Vmax remains unchanged because competitive inhibitors can be overcome at high substrate concentrations. The inhibitor competes with substrate for the active site, requiring higher substrate concentrations to achieve half-maximal velocity but not affecting the maximum velocity achievable when substrate outcompetes inhibitor. This demonstrates the quantitative relationship between inhibitor concentration, Ki, and the degree of inhibition. A common misconception is that competitive inhibitors affect Vmax, confusing this with noncompetitive inhibition. To calculate competitive inhibition effects, use the formula: apparent Km = Km(1 + [I]/Ki) and remember that Vmax is unchanged.
An enzyme involved in intestinal carbohydrate digestion uses two active-site residues: Asp (general acid) and His (general base). Site-directed mutagenesis replaces Asp with Asn (D→N) without altering overall folding (confirmed by circular dichroism). At pH 7.0, the mutant shows unchanged substrate binding affinity but a 100-fold decrease in $k_{cat}$. Which statement best explains the catalytic mechanism of the enzyme?
Asp is required primarily for global protein stability; replacing it disrupts tertiary structure and indirectly lowers activity.
Asp determines substrate specificity by forming the only binding contact; replacing it should primarily increase $K_m$.
Asp participates directly in acid catalysis; replacing it removes a proton donor/acceptor needed to stabilize the transition state, lowering $k_{cat}$.
Asp increases reaction spontaneity by making $\Delta G^\circ$ more negative; replacing it increases $\Delta G^\circ$ and slows the rate.
Explanation
This question tests understanding of catalytic mechanisms and the role of specific amino acid residues in enzyme function. General acid-base catalysis involves amino acid residues that donate or accept protons to stabilize transition states and facilitate bond breaking/formation, with aspartate commonly serving as a general acid due to its carboxyl group. The mutation from Asp to Asn removes the ionizable carboxyl group while maintaining similar size and polarity, explaining why substrate binding (Km) is unchanged but catalytic rate (kcat) drops 100-fold. The intact protein folding rules out global structural disruption, pointing to a direct catalytic role for the aspartate. A common error is assuming all active site residues primarily affect substrate binding, but catalytic residues specifically stabilize transition states. When analyzing mutagenesis data, distinguish between effects on binding (Km changes) versus catalysis (kcat changes) to identify residue functions.
A cytosolic enzyme is regulated by phosphorylation at a site distant from the active site. Phosphorylation increases $V_{max}$ with no change in $K_m$. Structural data indicate a shift toward an active conformation that better aligns catalytic residues. Which statement is most consistent with this regulation?
Phosphorylation increases catalytic turnover by increasing the fraction of enzyme in a catalytically competent conformation, raising $k_{cat}$.
Phosphorylation increases substrate binding affinity, so $K_m$ must decrease while $V_{max}$ stays constant.
Phosphorylation acts as a competitive inhibitor by occupying the active site, increasing $K_m$.
Phosphorylation changes reaction equilibrium, so $K_{eq}$ increases and $V_{max}$ increases.
Explanation
This question tests understanding of allosteric regulation through post-translational modification and its effects on enzyme catalysis. Phosphorylation at a site distant from the active site induces a conformational change that better aligns catalytic residues, increasing the catalytic rate constant (kcat) and thus Vmax without affecting substrate binding affinity (Km unchanged). This demonstrates how covalent modification can regulate enzyme activity by altering the three-dimensional arrangement of catalytic residues rather than substrate binding sites. The structural data confirming a shift to an active conformation provides mechanistic insight into how phosphorylation increases catalytic efficiency. A common error is assuming phosphorylation must affect substrate binding, but allosteric regulation can selectively modulate catalysis. When analyzing enzyme regulation, consider how conformational changes induced by modifications can differentially affect binding versus catalytic steps.
An enzyme-catalyzed reaction is measured at 37°C with saturating substrate. A reversible inhibitor binds at the active site and forms only noncovalent interactions. Immediately after adding inhibitor, $v_0$ decreases but returns to baseline after the inhibitor is diluted 100-fold. Which statement is most consistent with this observation?
The inhibitor decreases $\Delta G^\circ$; dilution restores activity by shifting equilibrium toward products.
The inhibitor binds only to ES; dilution restores activity because $K_m$ decreases and enzyme becomes saturated.
The inhibitor irreversibly inactivates enzyme by covalent modification; dilution restores activity by increasing substrate concentration.
The inhibitor is reversible; lowering its concentration shifts binding equilibrium toward free enzyme, restoring activity.
Explanation
This question tests understanding of reversible inhibition and the principle of mass action in enzyme-inhibitor interactions. Reversible inhibitors form only noncovalent interactions and exist in equilibrium with free enzyme and inhibitor, so diluting the system shifts the equilibrium toward dissociation, reducing the fraction of enzyme-inhibitor complex and restoring activity. The immediate decrease upon inhibitor addition followed by recovery after dilution confirms reversible binding rather than covalent modification or irreversible inactivation. This behavior is consistent with competitive inhibition at the active site, where the inhibitor can readily associate and dissociate. A common error is confusing reversible and irreversible inhibition - irreversible inhibitors would not show activity restoration upon simple dilution. To distinguish reversible from irreversible inhibition, test whether activity can be restored by dilution or dialysis, which removes free inhibitor and shifts the binding equilibrium.
A protease recognizes a specific peptide sequence via a deep specificity pocket. A point mutation narrows the pocket volume without altering catalytic residues. The enzyme shows strongly reduced activity toward the original substrate but normal activity toward a smaller peptide substrate. Which statement best explains the enzyme behavior?
The mutation creates competitive inhibition by the smaller peptide, which increases $V_{max}$ for the original substrate.
Because catalytic residues are unchanged, substrate identity should not affect rate; activity should be identical for both peptides.
Altering pocket geometry changes $K_{eq}$ for the reaction, selectively reducing product formation for the original substrate.
Altering pocket geometry changes substrate specificity by affecting binding complementarity, reducing catalysis for substrates that no longer fit.
Explanation
This question tests understanding of enzyme substrate specificity and how active site architecture determines which substrates can be effectively processed. The specificity pocket provides shape complementarity for substrate recognition, and narrowing this pocket prevents proper binding of the original larger substrate while allowing a smaller substrate that fits the new dimensions to bind and be processed normally. This demonstrates that substrate specificity depends on the precise fit between enzyme and substrate, independent of the catalytic residues that remain unchanged. The differential activity toward different substrates confirms that binding geometry, not just catalytic chemistry, determines enzyme specificity. A common misconception is that unchanged catalytic residues guarantee unchanged activity for all substrates, but substrate recognition is equally important. When analyzing specificity mutations, consider how changes in binding pocket geometry affect different substrates based on their size and shape.
An enzyme that catalyzes a redox reaction uses NAD$^+$ as a cosubstrate. In an assay where NAD$^+$ is limiting, increasing substrate S does not increase $v_0$ beyond a low plateau. Adding excess NAD$^+$ restores a higher plateau rate. Which statement best explains the observed behavior?
NAD$^+$ acts as a required reactant; when NAD$^+$ is limiting, the reaction rate becomes constrained by NAD$^+$ availability rather than [S].
NAD$^+$ changes $\Delta G^\circ$; adding NAD$^+$ shifts equilibrium and therefore increases initial rate.
NAD$^+$ is a noncompetitive inhibitor; adding more NAD$^+$ relieves inhibition and increases $V_{max}$.
NAD$^+$ determines substrate specificity; limiting NAD$^+$ should increase $K_m$ for S but not affect maximal rate.
Explanation
This question tests understanding of multi-substrate enzyme reactions and how limiting cosubstrate availability affects observed kinetics. In redox reactions requiring NAD+ as a cosubstrate, the overall reaction rate depends on both substrate S and NAD+ availability, following a two-substrate kinetic mechanism where both must bind for catalysis to occur. When NAD+ is limiting, the reaction rate plateaus at a level determined by NAD+ concentration regardless of how much substrate S is added, because every catalytic cycle requires both S and NAD+. Adding excess NAD+ removes this limitation, allowing a higher plateau rate limited by enzyme and substrate S concentrations. A common error is treating NAD+ as an allosteric regulator rather than a required reactant. When analyzing multi-substrate reactions, consider that the rate depends on the limiting reactant, and apparent saturation kinetics can reflect limitation by any required substrate.
A drug candidate binds reversibly to an enzyme active site. When S is increased from 1 \muM to 1 mM, inhibition is largely overcome and $V_{max}$ approaches the uninhibited value. Which outcome is most consistent with the presence of a competitive inhibitor?
Inhibitor decreases $V_{max}$ because it binds only to ES and cannot be displaced by substrate.
Inhibitor changes $K_{eq}$, so increasing [S] restores $V_{max}$ by shifting equilibrium.
Inhibitor increases apparent $K_m$ because higher [S] is required to achieve half-maximal velocity.
Inhibitor decreases apparent $K_m$ by stabilizing ES, shifting the curve left.
Explanation
This question tests understanding of competitive inhibition and its defining characteristic of being overcome by excess substrate. Competitive inhibitors bind reversibly to the active site, competing directly with substrate, which means increasing substrate concentration can displace the inhibitor and restore activity to approach the uninhibited Vmax. The observation that increasing [S] from 1 μM to 1 mM largely overcomes inhibition confirms competitive binding, as the high substrate concentration effectively outcompetes the inhibitor for active site occupancy. This results in an increased apparent Km (more substrate needed for half-maximal velocity) while Vmax remains theoretically unchanged at infinite substrate concentration. A common misconception is that competitive inhibitors permanently reduce enzyme activity, but they can always be overcome by sufficient substrate. To identify competitive inhibition experimentally, test whether increasing substrate concentration restores activity toward the uninhibited maximum.
A purified cytosolic enzyme (E) catalyzes conversion of substrate S to product P. Initial rates $v_0$ were measured at 37°C with varying S in the presence or absence of inhibitor I. The inhibitor is not consumed. Data: without I, $V_{max}=120\ \mu$M/min and $K_m=10\ \mu$M; with 20 \muM I, $V_{max}=120\ \mu$M/min and apparent $K_m=40\ \mu$M. Which outcome is most consistent with the presence of a competitive inhibitor?
The inhibitor decreases apparent $K_m$ because it stabilizes the enzyme–substrate complex relative to free enzyme.
The inhibitor increases apparent $K_m$ while leaving $V_{max}$ unchanged because it competes with S for binding to the active site.
The inhibitor leaves both $K_m$ and $V_{max}$ unchanged because it binds only to the enzyme–substrate complex.
The inhibitor decreases $V_{max}$ by reducing the catalytic turnover number $k_{cat}$ at all substrate concentrations.
Explanation
This question tests understanding of competitive inhibition and its effects on enzyme kinetics. Competitive inhibitors bind reversibly to the enzyme's active site, competing directly with substrate for binding, which increases the apparent Km (the substrate concentration needed for half-maximal velocity) while leaving Vmax unchanged because sufficient substrate can outcompete the inhibitor. The data shows Vmax remains at 120 μM/min while apparent Km increases from 10 to 40 μM with inhibitor, perfectly matching competitive inhibition. At high substrate concentrations, the inhibitor is displaced from the active site, allowing the enzyme to reach its original maximum velocity. A common misconception is that competitive inhibitors reduce Vmax, but this confuses competitive with noncompetitive inhibition. To identify competitive inhibition, check if Vmax stays constant while Km increases, and remember that competitive inhibitors can be overcome by adding more substrate.
A mitochondrial dehydrogenase was assayed at 25°C using saturating substrate. Addition of 10 \muM inhibitor X decreases $V_{max}$ from 200 to 80 nmol/min but leaves $K_m$ unchanged at 5 \muM. The inhibitor binds both free enzyme and enzyme–substrate complex with similar affinity. Based on the vignette, which outcome is most consistent with the presence of a noncompetitive inhibitor?
The inhibitor decreases both $K_m$ and $V_{max}$ by binding only to the enzyme–substrate complex.
The inhibitor decreases $V_{max}$ without changing $K_m$ because it reduces the fraction of catalytically competent enzyme.
Increasing [S] to very high levels fully restores the original $V_{max}$ because X is displaced from the active site.
The inhibitor increases $K_m$ without changing $V_{max}$ by preventing substrate binding to the active site.
Explanation
This question tests understanding of noncompetitive inhibition and its characteristic kinetic signature. Noncompetitive inhibitors bind to sites distinct from the active site and can bind to both free enzyme and enzyme-substrate complex with similar affinity, reducing the fraction of catalytically active enzyme without affecting substrate binding. The data shows Vmax decreases from 200 to 80 nmol/min while Km remains unchanged at 5 μM, which is the hallmark of pure noncompetitive inhibition. Unlike competitive inhibition, increasing substrate concentration cannot overcome noncompetitive inhibition because the inhibitor doesn't compete for the active site. A common misconception is that all inhibitors must affect either Km or Vmax exclusively, but mixed inhibition affects both parameters. To identify noncompetitive inhibition, look for decreased Vmax with unchanged Km, indicating the inhibitor reduces catalytic efficiency without interfering with substrate binding.
A serine protease contains a catalytic triad (Ser, His, Asp). A small molecule Y covalently modifies the active-site Ser hydroxyl, forming a stable ester that does not hydrolyze during the assay. Enzyme concentration and substrate concentration are unchanged. Which statement best explains the catalytic mechanism of the enzyme under these conditions?
Covalent modification of Ser makes the reaction thermodynamically unfavorable by increasing $\Delta G^\circ$.
Covalent modification of Ser increases substrate binding, decreasing $K_m$ and increasing catalytic efficiency.
Covalent modification of Ser decreases effective active enzyme concentration, lowering $V_{max}$ regardless of substrate concentration.
Covalent modification of Ser is equivalent to competitive inhibition and can be fully overcome by increasing [S].
Explanation
This question tests understanding of irreversible enzyme inhibition through covalent modification of catalytic residues. Serine proteases use a catalytic triad mechanism where the serine hydroxyl acts as a nucleophile, and covalent modification of this serine by forming a stable ester effectively removes the enzyme from the active pool, reducing the concentration of functional enzyme. This type of inhibition decreases Vmax because fewer enzyme molecules are capable of catalysis, regardless of substrate concentration - the hallmark of irreversible inhibition. Unlike reversible competitive inhibition, increasing substrate cannot restore activity because the modified enzyme molecules are permanently inactivated. A common error is thinking covalent modification acts like competitive inhibition, but competitive inhibitors bind reversibly and can be displaced by substrate. When analyzing covalent inhibitors, remember they reduce effective enzyme concentration, mimicking the effect of using less enzyme in the assay.